Friedrich M. Haag
Hamburg, HH, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 86 publications
Methodological guidelines for P2X receptor assays and data interpretation.
Journal: Cell death & disease
Published: January 18, 2026
Novel Bispecific Engagers Targeting the CεmX Domain of mIgE-Expressing Cells.
Journal: Allergy
Published: April 04, 2025
ENPP1/CD203a-targeting heavy-chain antibody reveals cell-specific expression on human immune cells.
Journal: Cellular and molecular life sciences : CMLS
Published: September 26, 2024
ATP-Gated P2X7-Ion Channel on Kidney-Resident Natural Killer T Cells and Memory T Cells in Intrarenal Inflammation.
Journal: Journal of the American Society of Nephrology : JASN
Published: May 30, 2024
Generation and characterization of antagonistic anti-human CD39 nanobodies.
Journal: Frontiers in immunology
Published: October 26, 2023
Generation of nanobodies from transgenic 'LamaMice' lacking an endogenous immunoglobulin repertoire.
Generation of nanobodies from transgenic 'LamaMice' lacking an endogenous immunoglobulin repertoire.
Journal: Nature communications
Published: October 23, 2023
Immunosuppressive M2 TAMs represent a promising target population to enhance phagocytosis of ovarian cancer cells in vitro.
Journal: Frontiers in immunology
Published: June 29, 2023
Non-organ-specific autoantibodies with unspecific patterns are a frequent para-infectious feature of chronic hepatitis D.
Journal: Frontiers in medicine
Published: February 18, 2023
TIGIT blockade repolarizes AML-associated TIGIT+ M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosis.
Journal: Journal for immunotherapy of cancer
Published: October 27, 2022
Origin, distribution, and function of three frequent coding polymorphisms in the gene for the human P2X7 ion channel.
Journal: Frontiers in pharmacology
Published: August 31, 2022
Effective targeting of microglial P2X7 following intracerebroventricular delivery of nanobodies and nanobody-encoding AAVs.
Journal: Frontiers in pharmacology
Published: August 27, 2022
Last Updated: 09/26/2026